MARK CORRIGAN - 02 Jun 2021 Form 4 Insider Report for Nabriva Therapeutics plc (NBRV)

Role
Director
Signature
/s/ Robert Crotty, by power of attorney
Issuer symbol
NBRV
Transactions as of
02 Jun 2021
Net transactions value
$0
Form type
4
Filing time
04 Jun 2021, 17:50:19 UTC
Next filing
30 Jul 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NBRV Share Options Award $0 +10,500 $0.000000 10,500 02 Jun 2021 Ordinary Shares 10,500 $1.39 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option was granted on June 2, 2021.
F2 The option will vest over a three-year period on a monthly pro rata basis beginning on June 2, 2021 and subject to the Reporting Person's continued service on the board of directors of the Issuer.